drugset / Trial / NCT00910091
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial will explore the safety and efficacy of BN83485 compared to Megestrol Acetate (MA) on progression free survival (PFS) in post menopausal patients with endometrial cancer.
Timeline
- Start
- 2009-08
- Primary completion
- 2012-01
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irosustat | Small molecule | 40 mg | Oral |
| Comparator | Megestrol Acetate | Other / unclassified | 160 mg | Oral |